Sean Lee
Stock Analyst at HC Wainwright & Co.
(1.63)
# 1480
Out of 5,337 analysts
107
Total ratings
35.38%
Success rate
22.88%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
VSTM Verastem | Maintains: Strong Buy | 10 14 | 7.08 | 97.74% | 14 | May 9, 2025 | |
DWTX Dogwood Therapeutics | Upgrades: Buy | 10 | 4.83 | 107.04% | 1 | Apr 23, 2025 | |
ATEC Alphatec Holdings | Reiterates: Buy | 20 20 | 12.77 | 56.62% | 12 | Apr 14, 2025 | |
CASI CASI Pharmaceuticals | Maintains: Buy | 6 4 | 1.89 | 111.64% | 8 | Apr 9, 2025 | |
CTSO CytoSorbents | Reiterates: Neutral | 1 1 | 0.82 | 21.95% | 12 | Apr 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 40 | 37.4 | 6.95% | 10 | Apr 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 6 | 0.54 | 918.52% | 11 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 11 11 | 3.62 | 203.87% | 3 | Mar 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 8 10 | 3.27 | 190.52% | 5 | Mar 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 5 | n/a | n/a | 4 | Oct 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 1 | n/a | n/a | 14 | Oct 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 100 100 | 3.64 | 2647.25% | 4 | Jul 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 7 | Nov 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 1.35 | 2122.22% | 1 | Dec 5, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Mar 19, 2021 |